|
受注:045-509-1970 |
技術サポート:tech@selleck.co.jp 平日9:00〜18:00 1営業日以内にご連絡を差し上げます |
|
Synonyms | N/A | Storage (From the date of receipt) |
3 years -20°C powder 1 years -80°C in solvent |
|||||||||||
| 化学式 | C20H19N5 |
||||||||||||||
| 分子量 | 329.4 | CAS No. | 244767-67-7 | ||||||||||||
| Solubility (25°C)* | 体外 | DMSO | 34 mg/mL (103.21 mM) | ||||||||||||
| Water | Insoluble | ||||||||||||||
| Ethanol | Insoluble | ||||||||||||||
| 体内 (毎回新しく調製した物を用意してください) |
|
||||||||||||||
|
* <1 mg/ml means slightly soluble or insoluble. * Please note that Selleck tests the solubility of all compounds in-house, and the actual solubility may differ slightly from published values. This is normal and is due to slight batch-to-batch variations. |
|||||||||||||||
| 製品説明 | Dapivirine (TMC120)は、IC50が24 nMのHIV逆転写酵素の非ヌクレオシド阻害剤であり、広範なNNRTI耐性株を含む、異なるクラスのHIV-1分離株の広範なパネルを阻害します。第3相。 |
|---|---|
| in vitro | Dapivirine (TMC120) prevents HIV-induced syncytium formation in the nanomolar range and shows a low cytostatic activity. It apparently blocks HIV-1 infection in the primary cultures at a 10 nM concentration, but secondary cultures reveals that a 100 nM concentration is needed to completely prevent proviral integration. This compound is well tolerated by epithelial cells, T cells, macrophages, and cervical tissue explants with CC50 (50% cytotoxic concentration) of 10 μM to 20 μM. It potently inhibits infection by both X4- and R5-utilizing HIV-1 strains with IC50 of 1.46 nM in cell-based assays. Dapivirine potently inhibits HIV-1BaL infection of human ectocervical explant tissue in a dose-dependent manner, as evaluated by the reduction in both p24 release and provirus content in cultured explants. It inhibits the transmission of virus to permissive T cells in a dose-dependent manner, with an IC50 of 0.1 nM. This compound results in significant inhibition of HIV infection when explants are challenged with virus immediately with IC90 of 100 nM. It is also able to inhibit viral dissemination by migratory cells. |
| in vivo | Dapivirine (TMC120)-containing gel at vaginal level inhibits cell-associated HIV infection in mice. More placebo (7 of 12) than this compound (3 of 24) gel users has positive vaginal swab results, with white blood cells being the most common finding. It results in Cmax of 715 pg/mL, AUC of 15 ng×h/mL and T1/2 of 89.87 hours in plasma after 14 days post-dose. Mean concentrations of this compound (0.05%) in vaginal fluids collected at the introitus, mid vagina, and cervix are in the range of 62-265 μg/g on day 1. |
|
| Expression of Genes for Drug Transporters in the Human Female Genital Tract and Modulatory Effect of Antiretroviral Drugs [ PLOS One, June 23, 2015, e0131405] | PubMed: 26102284 |
| Antitumor Activity and Mechanism of a Reverse Transcriptase Inhibitor, Dapivirine, in Glioblastoma [ Journal of Cancer, January 01, 2018, 117-128] | PubMed: 29290776 |
| Drug transporter gene expression in human colorectal tissue and cell lines: modulation with antiretrovirals for microbicide optimization [ Journal of Antimicrobial Chemotherapy, February 15, 2016, 372-386] | |
| Multifaceted impact of HIV inhibitor dapivirine on triple negative breast cancer cells reveals potential entities as targets for novel therapy [ Scientific Reports, December 3, 2024, 30103] | PubMed: 39627279 |
| Next-generation 3D printed multipurpose prevention intravaginal ring for prevention of HIV, HSV-2, and unintended pregnancy [ Journal of Controlled Release, December 2024, 1209-1224] | PubMed: 39500407 |
| Reciprocal Modulation of Antiretroviral Drug and Steroid Receptor Function In Vitro [ Antimicrobial Agents and Chemotherapy, December 20, 2019, e01890-19] | PubMed: 31658973 |
| Next-generation 3D printed multipurpose prevention intravaginal ring for prevention of HIV, HSV-2, and unintended pregnancy [ J Control Release, 2024, 376:1209-1224] | PubMed: 39500407 |
| Multifaceted impact of HIV inhibitor dapivirine on triple negative breast cancer cells reveals potential entities as targets for novel therapy [ Sci Rep, 2024, 14(1):30103] | PubMed: 39627279 |
| Comprehensive Study of Antiretroviral Drug Permeability at the Cervicovaginal Mucosa via an In Vitro Model [ Pharmaceutics, 2022, 14(9)1938] | PubMed: 36145684 |
| Female Genital Fibroblasts Diminish the In Vitro Efficacy of PrEP against HIV [ Viruses, 2022, 14(8)1723] | PubMed: 36016345 |
長期の保管のために-20°Cの下で製品を保ってください。
人間や獣医の診断であるか治療的な使用のためにでない。
各々の製品のための特定の保管と取扱い情報は、製品データシートの上で示されます。大部分のSelleck製品は、推薦された状況の下で安定です。製品は、推薦された保管温度と異なる温度で、時々出荷されます。長期の保管のために必要とされてそれと異なる温度で、多くの製品は、短期もので安定です。品質を維持するが、夜通しの積荷のために最も経済的な貯蔵状況を用いてあなたの送料を保存する状況の下に、製品が出荷されることを、我々は確実とします。製品の受領と同時に、製品データシートの上で貯蔵推薦に従ってください。